CANCER 2026 Victoria Tyma
Garvan Institute of Medical Research, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Co-targeting thrombospondin-1 (THBS-1) to improve KRAS inhibitor and chemotherapeutic efficacy in pancreatic cancer (#268)
5:35 PM
Victoria M Tyma
Poster Session 2
Targeting the NPY/NPY1R signaling axis impairs metastasis and tissue wasting in pancreatic cancer (#159)
5:40 PM
David Herrmann
Welcome Reception & Poster Session 1